IRIS Accounts Production v25.1.3.33 09355143 director 1.9.23 31.8.24 31.8.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093551432023-08-31093551432024-08-31093551432023-09-012024-08-31093551432022-08-31093551432022-09-012023-08-31093551432023-08-3109355143ns15:EnglandWales2023-09-012024-08-3109355143ns14:PoundSterling2023-09-012024-08-3109355143ns10:Director12023-09-012024-08-3109355143ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3109355143ns10:SmallEntities2023-09-012024-08-3109355143ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3109355143ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3109355143ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3109355143ns10:FullAccounts2023-09-012024-08-3109355143ns10:RegisteredOffice2023-09-012024-08-3109355143ns5:CurrentFinancialInstruments2024-08-3109355143ns5:CurrentFinancialInstruments2023-08-3109355143ns5:Non-currentFinancialInstruments2024-08-3109355143ns5:Non-currentFinancialInstruments2023-08-3109355143ns5:ShareCapital2024-08-3109355143ns5:ShareCapital2023-08-3109355143ns5:RetainedEarningsAccumulatedLosses2024-08-3109355143ns5:RetainedEarningsAccumulatedLosses2023-08-3109355143ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-09-012024-08-3109355143ns5:PlantMachinery2023-09-012024-08-3109355143ns5:FurnitureFittings2023-09-012024-08-3109355143ns5:ComputerEquipment2023-09-012024-08-3109355143ns5:LandBuildings2023-08-3109355143ns5:PlantMachinery2023-08-3109355143ns5:FurnitureFittings2023-08-3109355143ns5:ComputerEquipment2023-08-3109355143ns5:LandBuildings2023-09-012024-08-3109355143ns5:LandBuildings2024-08-3109355143ns5:PlantMachinery2024-08-3109355143ns5:FurnitureFittings2024-08-3109355143ns5:ComputerEquipment2024-08-3109355143ns5:LandBuildings2023-08-3109355143ns5:PlantMachinery2023-08-3109355143ns5:FurnitureFittings2023-08-3109355143ns5:ComputerEquipment2023-08-3109355143ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3109355143ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-310935514312023-09-012024-08-31
REGISTERED NUMBER: 09355143 (England and Wales)
























Unaudited Financial Statements

for the Year Ended 31 August 2024

for

Newcore Healthcare Limited

Newcore Healthcare Limited (Registered number: 09355143)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Newcore Healthcare Limited

Company Information
for the Year Ended 31 August 2024







Director: Dr B P Choudhary





Registered office: 101 Dunraven St
Tonypandy
Rhondda Cynon Taff
CF40 1AR





Registered number: 09355143 (England and Wales)





Accountants: Curtis Bowden & Thomas Limited
Chartered Certified Accountants
101 Dunraven Street
Tonypandy
CF40 1AR

Newcore Healthcare Limited (Registered number: 09355143)

Statement of Financial Position
31 August 2024

31.8.24 31.8.23
Notes £    £    £   
Fixed assets
Tangible assets 4 863,207 888,769

Current assets
Debtors 5 129,118 136,282
Cash at bank and in hand 95,494 64,117
224,612 200,399
Creditors
Amounts falling due within one year 6 662,423 694,731
Net current liabilities (437,811 ) (494,332 )
Total assets less current liabilities 425,396 394,437

Creditors
Amounts falling due after more than one
year

7

951,271

947,199
Net liabilities (525,875 ) (552,762 )

Capital and reserves
Called up share capital 300 300
Retained earnings (526,175 ) (553,062 )
Shareholders' funds (525,875 ) (552,762 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 May 2025 and were signed by:



Dr B P Choudhary - Director


Newcore Healthcare Limited (Registered number: 09355143)

Notes to the Financial Statements
for the Year Ended 31 August 2024

1. Statutory information

Newcore Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The company's trading address is 53 Brook Street, Williamstown CF40 1RE

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 52 (2023 - 55 ) .

Newcore Healthcare Limited (Registered number: 09355143)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

4. Tangible fixed assets
Fixtures
Freehold Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
Cost
At 1 September 2023 960,029 99,402 22,859 4,683 1,086,973
Additions - - 3,503 - 3,503
At 31 August 2024 960,029 99,402 26,362 4,683 1,090,476
Depreciation
At 1 September 2023 114,408 66,328 14,619 2,849 198,204
Charge for year 19,200 7,072 2,396 397 29,065
At 31 August 2024 133,608 73,400 17,015 3,246 227,269
Net book value
At 31 August 2024 826,421 26,002 9,347 1,437 863,207
At 31 August 2023 845,621 33,074 8,240 1,834 888,769

5. Debtors: amounts falling due within one year
31.8.24 31.8.23
£    £   
Trade debtors 61,705 63,541
Amounts owed by group undertakings 300 300
Other debtors 67,113 72,441
129,118 136,282

6. Creditors: amounts falling due within one year
31.8.24 31.8.23
£    £   
Bank loans and overdrafts 10,000 10,000
Trade creditors 111,632 153,061
Taxation and social security 70,816 89,395
Other creditors 469,975 442,275
662,423 694,731

7. Creditors: amounts falling due after more than one year
31.8.24 31.8.23
£    £   
Bank loans 9,166 19,166
Amounts owed to group undertakings 942,105 928,033
951,271 947,199

8. Secured debts

National Westminster Bank PLC has a fixed and floating charge on the property at 53 Brook Street, Williamstown.

Newcore Healthcare Limited (Registered number: 09355143)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

9. Related party disclosures

At the year end an amount of £942,105 (2023 - £928,033) is owed to BKM Limited.
Newcore Healthcare Limited and BKM Limited are wholly owned by Newcore Limited and hence form a small group.

Included in other creditors is an amount owed to Silvercrown Limited of £222,006 (2023 - £212,006) and Silvercrest Limited of £60,971 (2023 - £47,184). B Choudhary, a director of Newcore Healthcare Limited is also a director of both these companies.

10. Post balance sheet events

The company has negative reserves. Nursing homes had suffered substantial additional costs through the pandemic, but performance is expected to improve over the coming years. Both the bank ant the other companies within the group continue to support the company and the company remains a Going Concern

11. Ultimate controlling party

The controlling party is Dr B P Choudhary.